Publications

1. Mangioris G, Orozco E, Dubey D, Flanagan EP, Pittock SJ, Zekeridou A, McKeon A. Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study. J Neurol. 2024 Dec; 271 (12):7502-7515 Epub 2024 Sept 15
   View PubMed
2. Zhao-Fleming H, Rezk M, Shah S, Gupta P, Zekeridou A, Flanagan EP, Pittock SJ, McKeon A, Dubey D. Comprehensive Analysis of Paraneoplastic Neurologic Syndrome and PNS-CARE Diagnostic Criteria in Clinical Practice. Neurol Neuroimmunol Neuroinflamm. 2024 Dec; 11 (6):e200316 Epub 2024 Sept 25
   View PubMed
3. Paramasivan NK, Masoud M, Karsten C, Zahid A, Kherbek H, Zekeridou A, Sista SR, Dasari S, Knight AM, Mangioris G, Mills JR, McKeon A, Pittock SJ, Dubey D. Phenotypic and oncological insights in ANNA1 autoimmunity: Age stratification and biomarker analysis. Ann Clin Transl Neurol. 2024 Nov 18 [Epub ahead of print]
   View PubMed
4. Vorasoot N, Abdulrahman YJ, Mateen F, Fryer JP, Redenbaugh V, Sagen JA, Musubire AK, Jenkins SM, Gorsh AP, Chen JJ, Zekeridou A, McKeon A, Flanagan EP, Mills JR, Pittock SJ. Dried blood spot improves global access to aquaporin-4-IgG testing for neuromyelitis optica. Ann Clin Transl Neurol. 2024 Nov; 11 (11):2855-2865 Epub 2024 Oct 15
   View PubMed
5. Nathoo N, Neyal N, Atkinson EJ, Weinshenker BG, Tillema JM, Keegan BM, Pittock SJ, Tobin WO, Flanagan EP, Gavrilova R, Toledano M, Young N, Truitt K, Okuda DT, Zeydan B, Kantarci OH. Multiple sclerosis in Somali Americans: Nature or nurture? Mult Scler Relat Disord. 2024 Oct; 90:105842 Epub 2024 Aug 29
   View PubMed
6. Bennett JL, Pittock SJ, Paul F, Kim HJ, Irani SR, O'Connor KC, Patterson KR, Smith MA, Gunsior M, Mittereder N, Rees WA, Cimbora D, Cree BAC. B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity. Ann Clin Transl Neurol. 2024 Oct; 11 (10):2792-2798 Epub 2024 Sept 02
   View PubMed
7. Mangioris G, Pittock SJ, Yang B, Fryer JP, Harmsen WS, Dubey D, Flanagan EP, Lopez-Chiriboga SA, McKeon A, Mills JR, Vodopivec I, Tobin WO, Toledano M, Aksamit AJ, Zekeridou A. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024 Oct; 96 (4):704-714 Epub 2024 July 19
   View PubMed
8. Tisavipat N, Rattanathamsakul N, Salman AR, Cacciaguerra L, Pittock SJ, Flanagan EP, Chen JJ. Intracranial Pressure Elevation and MOGAD. JAMA Neurol. 2024 Sep 16 Epub 2024 Sept 16
   View PubMed
9. Tajfirouz D, Madhavan A, Pacheco Marrero JM, Krecke KN, Fautsch KJ, Flanagan EP, Pittock SJ, Shah S, Bhatti MT, Chen JJ. Frequency of Asymptomatic Optic Nerve Enhancement in 203 Patients With MOG Antibody-Associated Disease. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11 (5):e200277 Epub 2024 June 26
   View PubMed
10. Clardy SL, Pittock SJ, Aktas O, Nakahara J, Isobe N, Centonze D, Fam S, Kielhorn A, Yu JC, Jansen J, Zhang I. Correction: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder. Neurol Ther. 2024 Aug; 13 (4):1313-1314
    View PubMed
11. Gilligan M, Lesnick CE, Guo Y, Bradshaw MJ, Ladha SS, Nowak M, Shah MP, Wittenborn JR, Basal E, Hinson S, Yang B, Dubey D, Mills JR, Pittock SJ, Zekeridou A, McKeon A. Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis. Ann Neurol. 2024 Jul; 96 (1):21-33 Epub 2024 Apr 18
    View PubMed
12. Redenbaugh V, Fryer JP, Cacciaguerra L, Chen JJ, Greenwood TM, Gilligan M, Thakolwiboon S, Majed M, Chia NH, McKeon A, Mills JR, Lopez Chiriboga AS, Tillema JM, Yang B, Abdulrahman Y, Guo K, Vorasoot N, Valencia Sanchez C, Tajfirouz DA, Toledano M, Zekeridou A, Dubey D, Gombolay GY, Caparo-Zamalloa C, Kister I, Pittock SJ, Flanagan EP. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid. Ann Neurol. 2024 Jul; 96 (1):34-45 Epub 2024 Apr 09
    View PubMed
13. Kherbek H, Itoh CY, Daley C, Eggers SD, Hinson S, Sarker P, Staff NP, Pittock SJ, Dubey D. Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia. J Neurol. 2024 Jul; 271 (7):4620-4627 Epub 2024 May 22
    View PubMed
14. Baker MJ, Kraker JA, Lee MS, Pittock SJ, Farnsworth PJ, Chen JJ. Perceived Fluctuation of MRI Findings in a Prolonged Course of the Heidenhain Variant of Creutzfeldt-Jakob Disease. J Neuroophthalmol. 2024 Jun 28 Epub 2024 June 28
    View PubMed
15. Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Bach C, Ravindran A, Sartori Valinotti JC, Bennani NN, Abeykoon JP, Shah MV, Hook CC, Rech KL, Go RS, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1):101 Epub 2024 June 20
    View PubMed
16. Wurtz LI, Knyazhanskaya E, Sohaei D, Prassas I, Pittock S, Willrich MAV, Saadeh R, Gupta R, Atkinson HJ, Grill D, Stengelin M, Thebault S, Freedman MS, Diamandis EP, Scarisbrick IA. Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis. Clin Proteomics. 2024 Jun 16; 21 (1):42 Epub 2024 June 16
    View PubMed
17. Clardy SL, Pittock SJ, Aktas O, Nakahara J, Isobe N, Centonze D, Fam S, Kielhorn A, Yu JC, Jansen J, Zhang I. Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder. Neurol Ther. 2024 Jun; 13 (3):535-549 Epub 2024 May 09
    View PubMed
18. Li X, Gupta P, Smith KM, Madhavan A, Rezk M, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Britton JW, Dubey D. Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis. Neurol Clin Pract. 2024 Jun; 14 (3):e200301 Epub 2024 May 07
    View PubMed
19. Cree BAC, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, She D, Rees W, Smith M, Cimbora D, Katz E, Bennett JL, N-MOmentum study investigators. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial. Lancet Neurol. 2024 Jun; 23 (6):588-602
    View PubMed
20. Mangioris G, Halfdanarson TR, Lennon VA, Chang BK, Dubey D, Dyck PJB, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Zekeridou A. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles. Eur J Neurol. 2024 Jun; 31 (6):e16273 Epub 2024 Mar 11
    View PubMed
21. Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ, Syc-Mazurek SB, Redenbaugh V, Lopez-Chiriboga AS, Valencia-Sanchez C, Hemingway C, Tillema JM, Ciccarelli O, Pittock SJ, Hacohen Y, Flanagan EP. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease. Neurology. 2024 May 28; 102 (10):e209303 Epub 2024 May 06
    View PubMed
22. Tisavipat N, Stiebel-Kalish H, Palevski D, Bialer OY, Moss HE, Chaitanuwong P, Padungkiatsagul T, Henderson AD, Sotirchos ES, Singh S, Salman AR, Tajfirouz DA, Chodnicki KD, Pittock SJ, Flanagan EP, Chen JJ. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11 (3):e200214 Epub 2024 Mar 28
    View PubMed
23. Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D. Peripheral nervous system manifestations of MOG antibody associated disease. Ann Clin Transl Neurol. 2024 Apr; 11 (4):1046-1052 Epub 2024 Jan 17
    View PubMed
24. Thakolwiboon S, Linnoila J, Pittock SJ, Dubey D, Zekeridou A. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome. J Neuroimmunol. 2024 Feb 15; 387:578293 Epub 2024 Jan 19
    View PubMed
25. Ortiz S, Pittock SJ, Berthele A, Levy M, Nakashima I, Oreja-Guevara C, Allen K, Mashhoon Y, Parks B, Kim HJ. Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Front Neurol. 2024; 15:1332890 Epub 2024 Jan 31
    View PubMed
26. Pittock SJ, Giometto B. Introduction and overview of immunopathological mechanisms and future directions. Handb Clin Neurol. 2024; 200:3-10
    View PubMed
27. Lee ST, Abboud H, Irani SR, Nakajima H, Piquet AL, Pittock SJ, Yeh EA, Wang J, Rajan S, Overell J, Smith J, St Lambert J, El-Khairi M, Gafarova M, Gelfand JM. Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO). Front Neurol. 2024; 15:1437913 Epub 2024 Aug 13
    View PubMed
28. Mckeon A, Pittock SJ. Overview and diagnostic approach in autoimmune neurology. CONTINUUM Lifelong Learning in Neurology. 2024; 30 (4):960-94
    
29. Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, Sechi E, Redenbaugh V, Morris PP, Carter JL, Wingerchuk DM, Tillema JM, Valencia-Sanchez C, Thakolwiboon S, Pittock SJ, Flanagan EP. Cerebral enhancement in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023 Dec 14; 95 (1):14-18
    View PubMed
30. Annane D, Pittock SJ, Kulkarni HS, Pickering BW, Khoshnevis MR, Siegel JL, Powell CA, Castro P, Fujii T, Dunn D, Smith K, Mitter S, Kazani S, Kulasekararaj A. Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2023 Dec; 11 (12):1051-1063 Epub 2023 Mar 20
    View PubMed
31. Cohen DA, Tajfirouz D, Vodopivec I, Kyle K, Bouffard MA, Bhattacharyya S, Douglas VC, Rasool N, Bhatti MT, McKeon A, Pittock S, Flanagan EP, Prasad S, Nagagopal V, Egan RA, Chen JJ, Chwalisz BK. Fluorescein Angiography Findings in Susac Syndrome: A Multicenter Retrospective Case Series. J Neuroophthalmol. 2023 Dec 1; 43 (4):481-490 Epub 2023 Apr 19
    View PubMed
32. Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muniz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Yang B, Montalvo Perero MJ, Montalvo M, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins. Ann Neurol. 2023 Dec; 94 (6):1086-1101 Epub 2023 Sept 19
    View PubMed
33. Samadzadeh S, Olesen MN, Wirenfeldt M, Moller S, Misu T, Soelberg K, Frederiksen JL, Heegaard S, Mariotto S, Fujihara K, Ruprecht K, Andersen TL, Marignier R, Lillevang ST, Flanagan EP, Pittock SJ, Kim HJ, Bennett JL, Paul F, Sorensen GL, Weinshenker BG, Lassmann H, Asgari N. Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects. Mult Scler. 2023 Dec; 29 (14):1721-1735 Epub 2023 Oct 13
    View PubMed
34. Majed M, Valencia Sanchez C, Bennett JL, Fryer J, Mulligan MD, Redenbaugh V, McKeon A, Mills JR, Wingerchuk DM, Lennon VA, Weinshenker B, Chen JJ, Flanagan EP, Pittock SJ, Kunchok A. Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis. Ann Neurol. 2023 Oct; 94 (4):727-735 Epub 2023 July 05
    View PubMed
35. Cacciaguerra L, Redenbaugh V, Chen JJ, Morris P, Sechi E, Syc-Mazurek SB, Lopez-Chiriboga AS, Tillema JM, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. 2023 Sep 26; 101 (13):e1376-e1381 Epub 2023 June 19
    View PubMed
36. Yang B, Brown A, McKeon A, Ahlskog JE, Tipton P, Guo Y, Lucchinetti C, Pittock SJ, Zekeridou A. Tenascin-R Autoimmunity: Isolated Tremor Reversed with Immunotherapy. Ann Neurol. 2023 Sep; 94 (3):502-507 Epub 2023 July 14
    View PubMed
37. Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M, Woodhall M, Paul F, Robertson NP, Lim M, Wassmer E, Kneen R, Huda S, Blain C, Halfpenny C, Hemingway C, O'Sullivan E, Hobart J, Fisniku LK, Martin RJ, Dobson R, Cooper SA, Williams V, Waters P, Chen JJ, Pittock SJ, Ramdas S, Leite MI, Flanagan EP, Geraldes R, Palace J. Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD? Ann Neurol. 2023 Sep; 94 (3):508-517 Epub 2023 July 12
    View PubMed
38. Aktas O, Hartung HP, Smith MA, Rees WA, Fujihara K, Paul F, Marignier R, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Cutter G, She D, Gunsior M, Cimbora D, Katz E, Cree BA, N-MOmentum study investigators. Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry. 2023 Sep; 94 (9):757-768 Epub 2023 May 23
    View PubMed
39. Smith KM, Britton JW, Thakolwiboon S, Chia NH, Gupta P, Flanagan EP, Zekeridou A, Lopez Chiriboga AS, Valencia Sanchez C, McKeon A, Pittock SJ, Dubey D. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023 Sep; 64 (9):2385-2398 Epub 2023 July 04
    View PubMed
40. McKeon A, Lesnick C, Vorasoot N, Buckley MW, Dasari S, Flanagan EP, Gilligan M, Lafrance-Corey R, Miske R, Pittock SJ, Scharf M, Yang B, Zekeridou A, Dubey D, Mills J. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease. Neurol Neuroimmunol Neuroinflamm. 2023 Sep; 10 (5) Epub 2023 Aug 07
    View PubMed
41. Valencia-Sanchez C, Sechi E, Dubey D, Flanagan EP, McKeon A, Pittock SJ, Zekeridou A. Immune checkpoint inhibitor-associated central nervous system autoimmunity. Eur J Neurol. 2023 Aug; 30 (8):2418-2429 Epub 2023 May 18
    View PubMed
42. Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks. Am J Ophthalmol. 2023 Aug; 252:213-224 Epub 2023 Feb 21
    View PubMed
43. Lotan I, Chen JJ, Hacohen Y, Abdel-Mannan O, Mariotto S, Huda S, Gibbons E, Wilf-Yarkoni A, Hellmann MA, Stiebel-Kalish H, Pittock SJ, Flanagan EP, Molazadeh N, Anderson M, Salky R, Romanow G, Schindler P, Duchow AS, Paul F, Levy M. Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease. Mult Scler. 2023 Aug; 29 (9):1080-1089 Epub 2023 July 10
    View PubMed
44. Webb LM, Cacciaguerra L, Krecke KN, Chen JJ, Sechi E, Redenbaugh V, Dubey D, Pittock SJ, Flanagan EP. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS. J Neurol Sci. 2023 Jul 15; 450:120687 Epub 2023 May 12
    View PubMed
45. Gadoth A, Devine MF, Pittock SJ, McKeon A, Tobin WO, Gossard TR, Cattaneo EFD, McCarter SJ, St Louis EK. Sleep disturbances associated with DPPX autoantibodies: a case series. J Neurol. 2023 Jul; 270 (7):3543-3552 Epub 2023 Apr 07
    View PubMed
46. Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett JL, Cree BAC, De Seze J, Fujihara K, Kim HJ, Hornby R, Huda S, Kissani N, Kleiter I, Kuwabara S, Lana-Peixoto M, Law L, Leite MI, Pandit L, Pittock SJ, Quan C, Ramanathan S, Rotstein D, Saiz A, Sato DK, Vaknin-Dembinsky A. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab. Neurol Neuroimmunol Neuroinflamm. 2023 Jul; 10 (4) Epub 2023 May 31
    View PubMed
47. Chia NH, McKeon A, Dalakas MC, Flanagan EP, Bower JH, Klassen BT, Dubey D, Zalewski NL, Duffy D, Pittock SJ, Zekeridou A. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. Ann Clin Transl Neurol. 2023 Jul; 10 (7):1083-1094 Epub 2023 May 22
    View PubMed
48. Weinshenker BG, Wingerchuk DM, Green AJ, Bennett JL, Kim HJ, Pittock SJ, Fujihara K, Paul F, Cutter G, Marignier R, Aktas O, Hartung HP, She D, Smith M, Rees W, Patterson K, Cimbora D, Katz E, Cree BA. Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum. Mult Scler. 2023 Jul; 29 (8):945-955 Epub 2023 June 06
    View PubMed
49. Tisavipat N, Chang BK, Ali F, Pittock SJ, Kammeyer R, Declusin A, Cohn SJ, Flanagan EP. Subacute Horizontal Diplopia, Jaw Dystonia, and Laryngospasm. Neurol Neuroimmunol Neuroinflamm. 2023 Jul; 10 (4) Epub 2023 June 13
    View PubMed
50. Pittock SJ, Barnett M, Bennett JL, Berthele A, de Seze J, Levy M, Nakashima I, Oreja-Guevara C, Palace J, Paul F, Pozzilli C, Yountz M, Allen K, Mashhoon Y, Kim HJ. Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Ann Neurol. 2023 Jun; 93 (6):1053-1068 Epub 2023 Apr 05
    View PubMed
51. Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, Zalewski N, Zekeridou A, Pittock SJ, McKeon A. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023 Jun; 13(3):e200151. Epub 2023 Apr 25.
    View PubMed
52. Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Mult Scler. 2023 Jun; 29 (7):799-808 Epub 2023 May 23
    View PubMed
53. Chia NH, Redenbaugh V, Chen JJ, Pittock SJ, Flanagan EP. Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler. 2023 May; 29 (6):748-752 Epub 2023 Jan 24
    View PubMed
54. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 Mar 28; 100 (13):e1418-e1432 Epub 2023 Jan 23
    View PubMed
55. Carta S, Cobo Calvo A, Armangue T, Saiz A, Lechner C, Rostasy K, Breu M, Baumann M, Hoftberger R, Ayzenberg I, Schwake C, Sepulveda M, Martinez-Hernandez E, Olive-Cirera G, Arrambide G, Tintore M, Bernard-Valnet R, Du Pasquier R, Brilot F, Ramanathan S, Schanda K, Gajofatto A, Ferrari S, Sechi E, Flanagan EP, Pittock SJ, Redenbaugh V, Reindl M, Marignier R, Mariotto S. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study. Neurology. 2023 Mar 14; 100 (11):e1095-e1108 Epub 2022 Dec 16
    View PubMed
56. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar; 22 (3):268-282 Epub 2023 Jan 24
    View PubMed
57. Dahl AR, M SJ, Pittock SJ, Pittock ST. Clinical Utility and Outcome Prediction of Early ZnT8-IgG Testing and Titer in Type 1 Diabetes. J Clin Res Pediatr Endocrinol. 2023 Feb 27; 15 (1):35-41 Epub 2022 Aug 19
    View PubMed
58. Stiebel-Kalish H, Rubarth K, Shouchane-Blum K, Tiosano A, Lotan I, Hellmann MA, Wilf-Yarkoni A, Bialer O, Flanagan EP, Pittock SJ, Bhatti MT, Schmitz-Hubsch T, Paul F, Asseyer S, Chen JJ. Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Sci Rep. 2023 Feb 20; 13 (1):2944
    View PubMed
59. McCombe JA, Zivelonghi C, Vorasoot N, Majed M, Flanagan EP, Dubey D, Pittock SJ, McKeon A, Zekeridou A. AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies. J Neuroimmunol. 2023 Feb 15; 375:578012 Epub 2022 Dec 23
    View PubMed
60. Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, Flanagan EP. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Ann Neurol. 2023 Feb; 93 (2):297-302 Epub 2022 Dec 02
    View PubMed
61. Gaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, Benson L, Chitnis T, Francisco C, Gorman MP, Goyal MS, Graves J, Greenberg BM, Hart J, Krupp L, Lotze T, Narula S, Pittock SJ, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Wheeler Y, Waubant E, Flanagan EP, United States Network of Pediatric Multiple Sclerosis Centers. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 Feb; 93 (2):271-284 Epub 2022 Oct 04
    View PubMed
62. Asseyer S, Asgari N, Bennett J, Bialer O, Blanco Y, Bosello F, Camos-Carreras A, Carnero Contentti E, Carta S, Chen J, Chien C, Chomba M, Dale RC, Dalmau J, Feldmann K, Flanagan EP, Froment Tilikete C, Garcia-Alfonso C, Havla J, Hellmann M, Kim HJ, Klyscz P, Konietschke F, La Morgia C, Lana-Peixoto M, Leite MI, Levin N, Levy M, Llufriu S, Lopez P, Lotan I, Lugaresi A, Marignier R, Mariotto S, Mollan SP, Ocampo C, Cosima Oertel F, Olszewska M, Palace J, Pandit L, Peralta Uribe JL, Pittock S, Ramanathan S, Rattanathamsakul N, Saiz A, Samadzadeh S, Sanchez-Dalmau B, Saylor D, Scheel M, Schmitz-Hubsch T, Shifa J, Siritho S, Sperber PS, Subramanian PS, Tiosano A, Vaknin-Dembinsky A, Mejia Vergara AJ, Wilf-Yarkoni A, Zarco LA, Zimmermann HG, Paul F, Stiebel-Kalish H. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Front Neurol. 2023; 14:1102353 Epub 2023 Feb 24
    View PubMed
63. Bennett JL, Fujihara K, Kim HJ, Marignier R, O'Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, Kunzel T, Lekkerkerker AN, Lennon-Chrimes S, Pittock SJ. SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Front Neurol. 2023; 14:1114667 Epub 2023 Feb 17
    View PubMed
64. Berthele A, Levy M, Wingerchuk DM, Pittock SJ, Shang S, Kielhorn A, Royston M, Sabatella G, Palace J. A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder. Front Neurol. 2023; 14:1099376 Epub 2023 Apr 11
    View PubMed
65. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80 (1):30-39
    View PubMed
66. Vorasoot N, Scharf M, Miske R, Thakolwiboon S, Dubey D, Mills JR, Pittock SJ, Zekeridou A, Ott A, McKeon A. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity. Front Immunol. 2023; 14:1265797 Epub 2023 Sept 29
    View PubMed
67. Rezk M, Pittock SJ, Kapadia RK, Knight AM, Guo Y, Gupta P, LaFrance-Corey RG, Zekeridou A, McKeon A, Dasari S, Mills JR, Dubey D. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome. Front Immunol. 2023; 14:1243946 Epub 2023 Sept 18
    View PubMed
68. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80(1):30-39. Epub 1900 Jan 01.
    View PubMed
69. Shelly S, Beecher G, Milone M, Liewluck T, Ernste F, Triplett J, Naddaf E, Zekeridou A, McKeon A, Pittock SJ, Dubey D, Mills JR, Mandrekar J, Klein CJ. Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation. Rheumatology (Oxford). 2022 Dec 23; 62 (1):281-289
    View PubMed
70. Stiebel-Kalish H, Rubarth K, Shouchane-Blum K, Tiosano A, Lotan I, Hellmann MA, Wilf-Yarkoni A, Bialer O, Flanagan EP, Pittock SJ, Bhatti MT, Schmitz-Hubsch T, Paul F, Asseyer S, Chen JJ. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Sci Rep. 2022 Dec 9; 12 (1):21312 Epub 2022 Dec 09
    View PubMed
71. Bennett JL, Aktas O, Rees WA, Smith MA, Gunsior M, Yan L, She D, Cimbora D, Pittock SJ, Weinshenker BG, Paul F, Marignier R, Wingerchuk D, Cutter G, Green A, Hartung HP, Kim HJ, Fujihara K, Levy M, Katz E, Cree BAC, N-MOmentum study investigators. Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial. EBioMedicine. 2022 Dec; 86:104321 Epub 2022 Nov 10
    View PubMed
72. Montalvo M, Khattak JF, Redenbaugh V, Britton J, Valencia Sanchez C, Sanchez CV, Datta A, Tillema JM, Chen J, McKeon A, Pittock SJ, Flanagan EP, Dubey D. Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody-associated disease. Epilepsia. 2022 Dec; 63 (12):3180-3191 Epub 2022 Oct 14
    View PubMed
73. Chen JJ, Flanagan EP, Bhatti MT, Tisavipat N, Jamali S, Kunchok A, Eggenberger ER, Nome MD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Seleme N, Mejia-Vergara AJ, Moss HE, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Hellmann MA, Vuppala A, Hodge D, Pittock SJ. Details and outcomes of a large cohort of MOG-IgG associated optic neuritis. Mult Scler Relat Disord. 2022 Dec; 68:104237. Epub 2022 Oct 10.
    View PubMed
74. Hinson SR, Honorat JA, Grund EM, Clarkson BD, Miske R, Scharf M, Zivelonghi C, Al-Lozi MT, Bucelli RC, Budhram A, Cho T, Choi E, Grell J, Lopez-Chiriboga AS, Levin M, Merati M, Montalvo M, Pittock SJ, Wilson MR, Howe CL, McKeon A. Septin-5 and -7-IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics. Ann Neurol. 2022 Dec; 92 (6):1090-1101 Epub 2022 Aug 27
    View PubMed
75. Syc-Mazurek SB, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, Flanagan EP. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. 2022 Oct 31; 99 (18):795-799
    View PubMed
76. Saadeh RS, Ramos PA, Algeciras-Schimnich A, Flanagan EP, Pittock SJ, Willrich MA. An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond. Clin Chem. 2022 Sep 1; 68 (9):1134-1150
    View PubMed
77. Hur M, Madhavan AA, Hodge DO, Eckel LJ, Pittock SJ, Flanagan EP, Bhatti MT, Chen JJ. Comparison of 1.5 Tesla and 3.0 Tesla Magnetic Resonance Imaging in the Evaluation of Acute Demyelinating Optic Neuritis. J Neuroophthalmol. 2022 Sep 1; 42 (3):297-302 Epub 2022 July 13
    View PubMed
78. Oertel FC, Sotirchos ES, Zimmermann HG, Motamedi S, Specovius S, Asseyer ES, Chien C, Cook L, Vasileiou E, Filippatou A, Calabresi PA, Saidha S, Pandit L, D'Cunha A, Outteryck O, Zephir H, Pittock S, Flanagan EP, Bhatti MT, Rommer PS, Bsteh G, Zrzavy T, Kuempfel T, Aktas O, Ringelstein M, Albrecht P, Ayzenberg I, Pakeerathan T, Knier B, Aly L, Asgari N, Soelberg K, Marignier R, Tilikete CF, Cobo Calvo A, Villoslada P, Sanchez-Dalmau B, Martinez-Lapiscina EH, Llufriu S, Green AJ, Yeaman MR, Smith TJ, Brandt AU, Chen J, Paul F, Havla J, with the GJCF International Clinical Consortium for NMOSD and the CROCTINO study group. Longitudinal Retinal Changes in MOGAD. Ann Neurol. 2022 Sep; 92 (3):476-485 Epub 2022 July 16
    View PubMed
79. Dahl A, Jenkins S, Pittock SJ, Mills J, Foster J, McKeon A, Pittock S. Comprehensive Diabetes Autoantibody Laboratory-Based Clinical Service Testing in 6044 Consecutive Patients: Analysis of Age and Sex Effects. J Appl Lab Med. 2022 Sep 1; 7 (5):1037-1046
    View PubMed
80. Shah SS, Morris P, Buciuc M, Tajfirouz D, Wingerchuk DM, Weinshenker BG, Eggenberger ER, Di Nome M, Pittock SJ, Flanagan EP, Bhatti MT, Chen JJ. Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD. Neurology. 2022 Aug 23; 99 (8):e851-e857 Epub 2022 June 13
    View PubMed
81. Dubey D, Beecher G, Hammami MB, Knight AM, Liewluck T, Triplett J, Datta A, Dasari S, Zhang Y, Roforth MM, Jerde CR, Murphy SJ, Litchy WJ, Amato A, Lennon VA, McKeon A, Mills JR, Pittock SJ, Milone M. Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. JAMA Neurol. 2022 Aug 01; 79(8):808-816.
    View PubMed
82. Bartley CM, Ngo TT, Alvarenga BD, Kung AF, Teliska LH, Sy M, DeRisi JL, Rasband MN, Pittock SJ, Dubey D, Wilson MR, Pleasure SJ. betaIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic Origin: A Case Series. Neurol Neuroimmunol Neuroinflamm. 2022 Jul; 9 (4) Epub 2022 May 17
    View PubMed
83. Montalvo M, Nallapaneni P, Hassan S, Nurko S, Pittock SJ, Khlevner J. Autoimmune gastrointestinal dysmotility following SARS-CoV-2 infection successfully treated with intravenous immunoglobulin. Neurogastroenterol Motil. 2022 Jul; 34 (7):e14314 Epub 2022 Jan 04
    View PubMed
84. McKeon-Makki I, McKeon A, Yang B, Pittock SJ, Lopez-Chiriboga S, Komorowski L, Miske R, Zekeridou A. Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients. J Neuroimmunol. 2022 Jun 15; 367:577861. Epub 2022 Apr 04.
    View PubMed
85. Guo Y, Lennon VA, Parisi JE, Popescu B, Vasquez C, Pittock SJ, Howe CL, Lucchinetti CF. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain. 2022 May 24; 145 (4):1379-1390
    View PubMed
86. Zekeridou A, Yang B, Lennon VA, Guo Y, Wu L, Lucchinetti CF, McKeon A, Pittock SJ, Flanagan EP. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol. 2022 May; 91 (5):670-675 Epub 2022 Mar 03
    View PubMed
87. Chen JJ, Huda S, Hacohen Y, Levy M, Lotan I, Wilf-Yarkoni A, Stiebel-Kalish H, Hellmann MA, Sotirchos ES, Henderson AD, Pittock SJ, Bhatti MT, Eggenberger ER, Di Nome M, Kim HJ, Kim SH, Saiz A, Paul F, Dale RC, Ramanathan S, Palace J, Camera V, Leite MI, Lam BL, Bennett JL, Mariotto S, Hodge D, Audoin B, Maillart E, Deschamps R, Pique J, Flanagan EP, Marignier R. Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2022 May 1; 79 (5):518-525
    View PubMed
88. McCombe JA, Pittock SJ. Anti-complement Agents for Autoimmune Neurological Disease. Neurotherapeutics. 2022 Apr; 19 (3):711-728 Epub 2022 May 12
    View PubMed
89. Saadeh RS, Bryant SC, McKeon A, Weinshenker B, Murray DL, Pittock SJ, Willrich MAV. CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis. Mayo Clin Proc. 2022 Apr; 97 (4):738-751 Epub 2021 Dec 08
    View PubMed
90. Peris Sempere V, Muniz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E. Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2022 Feb 03
    View PubMed
91. Pittock SJ, Fujihara K, Palace J, Berthele A, Kim HJ, Oreja-Guevara C, Nakashima I, Levy M, Shang S, Yountz M, Miller L, Armstrong R, Wingerchuk DM, PREVENT Study Group. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Mult Scler. 2022 Mar; 28 (3):480-486 Epub 2021 Sept 09
    View PubMed
92. Garrido Sanabria ER, Zahid A, Britton J, Kraus GJ, Lopez-Chiriboga AS, Zekeridou A, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Dubey D. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022 Mar; 63 (3):709-722 Epub 2022 Jan 15
    View PubMed
93. Wingerchuk DM, Zhang I, Kielhorn A, Royston M, Levy M, Fujihara K, Nakashima I, Tanvir I, Paul F, Pittock SJ. Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder. Neurol Ther. 2022 Mar; 11 (1):123-135 Epub 2021 Nov 13
    View PubMed
94. Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2021 Dec 22
    View PubMed
95. Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clin Proc. 2022 Mar; 97 (3):547-559 Epub 2021 Dec 23
    View PubMed
96. Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. 2022 Mar; 93 (3):309-315 Epub 2021 Nov 25
    View PubMed
97. Valencia-Sanchez C, Knight AM, Hammami MB, Guo Y, Mills JR, Kryzer TJ, Piquet AL, Amin A, Heinzelmann M, Lucchinetti CF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome. J Neurol Neurosurg Psychiatry. 2022 Feb; 93 (2):196-200 Epub 2021 Dec 17
    View PubMed
98. Chen JJ, Sotirchos ES, Henderson AD, Vasileiou ES, Flanagan EP, Bhatti MT, Jamali S, Eggenberger ER, Dinome M, Frohman LP, Arnold AC, Bonelli L, Seleme N, Mejia-Vergara AJ, Moss HE, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Hellmann MA, Hodge D, Oertel FC, Paul F, Saidha S, Calabresi PA, Pittock SJ. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS. Mult Scler Relat Disord. 2022 Feb; 58:103525 Epub 2022 Jan 11
    View PubMed
99. Bartley CM, Ngo TT, Cadwell CR, Harroud A, Schubert RD, Alvarenga BD, Hawes IA, Zorn KC, Hunyh T, Teliska LH, Kung AF, Shah S, Gelfand JM, Chow FC, Rasband MN, Dubey D, Pittock SJ, DeRisi JL, Wilson MR, Pleasure SJ. Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report. Front Neurol. 2022; 13:1102484 Epub 2023 Jan 23
    View PubMed
100. Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Neuroimaging features in inflammatory myelopathies: A review. Front Neurol. 2022; 13:993645 Epub 2022 Oct 18
     View PubMed
101. Zhao-Fleming HH, Zahid A, Lu T, Sun X, Pittock SJ, Lee HC, Dubey D. Characterization of cardiac bradyarrhythmia associated with LGI1-IgG autoimmune encephalitis. Front Immunol. 2022; 13:948479 Epub 2022 Oct 11
     View PubMed
102. Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol. 2022; 13:885218. Epub 2022 Jun 17.
     View PubMed
103. Marignier R, Pittock SJ, Paul F, Kim HJ, Bennett JL, Weinshenker BG, Wingerchuk DM, Green AJ, Fujihara K, Cutter G, Aktas O, Hartung HP, Drappa J, Ratchford JN, She D, Smith M, Rees W, Cimbora D, Katz E, Cree BAC, N-MOmentum study investigators. AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2022 Jan; 57:103356 Epub 2021 Nov 01
     View PubMed
104. Tajfirouz D, Padungkiatsagul T, Beres S, Moss HE, Pittock S, Flanagan E, Kunchok A, Shah S, Bhatti MT, Chen JJ. Optic chiasm involvement in AQP-4 antibody-positive NMO and MOG antibody-associated disorder. Mult Scler. 2022 Jan; 28 (1):149-153 Epub 2021 May 12
     View PubMed
105. Majed M, Madhavan AA, Pittock SJ, Dubey D. "Hot Cross Bun" Sign in a Patient With Kelch-like Protein 11 Rhombencephalitis. Mayo Clin Proc. 2022 Jan; 97 (1):122-123
     View PubMed
106. Chompoopong P, Zekeridou A, Shelly S, Ruff M, Dyck PJ, Klein CJ, Pittock SJ, Mauermann M, Dubey D. Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours. J Neurol Neurosurg Psychiatry 2022 Jan; 93 (1):112-114 Epub 2021 May 26
     View PubMed
107. Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021 Dec 14; 97 (24):e2392-e2403 Epub 2021 Oct 11
     View PubMed
108. Pittock SJ, Zekeridou A, Weinshenker BG. Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials. Nat Rev Neurol. 2021 Dec; 17 (12):759-773 Epub 2021 Oct 28
     View PubMed
109. Cree BA, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk D, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Williams IM, Drappa J, She D, Cimbora D, Rees W, Ratchford JN, Katz E. Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD. Mult Scler. 2021 Nov; 27 (13):2052-2061 Epub 2021 Feb 04
     View PubMed
110. Hammami MB, Eggers SDZ, Madhavan A, Montalvo MJ, Pittock SJ, Dubey D. Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations. J Neurol Neurosurg Psychiatry. 2021 Nov; 92 (11):1181-1185 Epub 2021 July 20
     View PubMed
111. Redenbaugh V, Montalvo M, Sechi E, Buciuc M, Fryer JP, McKeon A, Lennon VA, Mills JR, Weinshenker BG, Wingerchuk DM, Chen JJ, Tariq Bhatti M, Lopez Chiriboga AS, Pittock SJ, Flanagan EP. Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211052656 Epub 2021 Nov 26
     View PubMed
112. Mustafa R, Passe TJ, Lopez-Chiriboga AS, Weinshenker BG, Krecke KN, Zalewski NL, Diehn FE, Sechi E, Mandrekar J, Kaufmann TJ, Morris PP, Pittock SJ, Toledano M, Lanzino G, Aksamit AJ, Kumar N, Lucchinetti CF, Flanagan EP. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions. Neurol Clin Pract. 2021 Oct; 11 (5):e601-e611
     View PubMed
113. Zhao-Fleming HH, Valencia Sanchez C, Sechi E, Inbarasu J, Wijdicks EF, Pittock SJ, Chen JJ, Wingerchuk DM, Weinshenker BG, Lopez-Chiriboga S, Dubey D, Tillema JM, Toledano M, Yadav H, Flanagan EP. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 2021 Sep 28; 97 (13):e1351-e1358 Epub 2021 Aug 13
     View PubMed
114. Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, Weinshenker BG, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski NL, Tillema JM, Kunchok A, Monaco S, Morris PP, Fryer JP, Nguyen A, Greenwood T, Syc-Mazurek SB, Keegan BM, Flanagan EP. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. 2021 Sep 14; 97 (11):e1097-e1109 Epub 2021 July 14
     View PubMed
115. Marignier R, Hacohen Y, Cobo-Calvo A, Probstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Seze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 Sep; 20 (9):762-772
     View PubMed
116. Jitprapaikulsan J, Paul P, Thakolwiboon S, Mittal SO, Pittock SJ, Dubey D. Paraneoplastic neurological syndrome: an evolving story. Neurooncol Pract. 2021 Aug; 8(4):362-374. Epub 2021 Feb 24.
     View PubMed
117. Soares-Dos-Reis R, Tsz-Ching JL, Kim SH, Jacob A, Whittam D, Berthelot E, Paul F, Nakashima I, Tye JSN, De Seze J, Jitprapaikulsan J, Tan K, Yang L, Elsone L, Leite MI, Mealy MA, Levy M, Fan M, Siebert N, Asgari N, Cabre P, Siritho S, Pittock SJ, Wing-Ho SC, Senger T, Yeo T, Takai Y, Pandit L, Kim HJ, Palace J. Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence. Mult Scler Relat Disord. 2021 Aug; 53:103080 Epub 2021 June 15
     View PubMed
118. Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ. MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler. 2021 Jul; 27 (8):1175-1186 Epub 2020 Sept 10
     View PubMed
119. Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ, Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021 Jul; 92 (7):757-768 Epub 2021 Mar 01
     View PubMed
120. Shelly S, Mills JR, Dubey D, McKeon A, Zekeridou A, Pittock SJ, Harper CM, Naddaf E, Milone M, Mandrekar J, Klein CJ. Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology. 2021 Jun 14; 96 (24):e2966-e2976 Epub 2021 June 14
     View PubMed
121. Chen JJ, McKeon A, Greenwood TM, Flanagan EP, Bhatti MT, Dubey D, Pulido JS, Iezzi R, Smith WM, Sen HN, Gordon LK, Pittock SJ. Clinical Utility of Antiretinal Antibody Testing. JAMA Ophthalmol. 2021 Jun 1; 139 (6):658-662
     View PubMed
122. Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ, PREVENT Study Group. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Ann Neurol. 2021 Jun; 89 (6):1088-1098 Epub 2021 Feb 27
     View PubMed
123. Pittock SJ, Weitz I, Howard JF, Sabatella G, Mehta S, Franklin J. Response to: Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum disorder. CNS Spectr 2021 Jun; 26 (3):195-196 Epub 2020 July 09
     View PubMed
124. Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, Budhram A, Weinshenker BG, Lopez-Chiriboga AS, Tillema JM, McKeon A, Mills JR, Tobin WO, Flanagan EP. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing. JAMA Neurol. 2021 Jun 1; 78 (6):741-746
     View PubMed
125. Marignier R, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk D, Fujihara K, Paul F, Cutter GR, Green AJ, Aktas O, Hartung HP, Lublin FD, Williams IM, Drappa J, She D, Cimbora D, Rees W, Smith M, Ratchford JN, Katz E, Cree BAC, N-MOmentum Study Investigators. Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder. Neurol Neuroimmunol Neuroinflamm. 2021 May; 8 (3) Epub 2021 Mar 26
     View PubMed
126. Kim HJ, Nakashima I, Viswanathan S, Wang KC, Shang S, Miller L, Yountz M, Wingerchuk DM, Pittock SJ, Levy M, Berthele A, Totolyan N, Palace J, Barnett MH, Fujihara K, PREVENT Study Group. Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension. Mult Scler Relat Disord. 2021 May; 50:102849 Epub 2021 Feb 20
     View PubMed
127. Chen JJ, Pineles SL, Repka MX, Pittock SJ, Henderson RJ, Liu GT, Pediatric Eye Disease Investigator Group (PEDIG). MOG-IgG Among Participants in the Pediatric Optic Neuritis Prospective Outcomes Study. JAMA Ophthalmol 2021 May 1; 139 (5):583-585
     View PubMed
128. Smith KM, Zalewski NL, Budhram A, Britton JW, So E, Cascino GD, Ritaccio AL, McKeon A, Pittock SJ, Dubey D. Musicogenic epilepsy: Expanding the spectrum of glutamic acid decarboxylase 65 neurological autoimmunity. Epilepsia. 2021 May; 62 (5):e76-e81 Epub 2021 Mar 25
     View PubMed
129. Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA, Leibovich BC, Algeciras-Schimnich A, Lucchinnetti C, Hammami MB, Knight AM, Howe C, Lennon VA, McKeon A, Pittock SJ. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021 May; 89(5):1001-1010. Epub 2021 Feb 28.
     View PubMed
130. Sechi E, Messina S, Keegan BM, Buciuc M, Pittock SJ, Kantarci OH, Weinshenker BG, Flanagan EP. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study. Mult Scler. 2021 Apr; 27 (5):667-673 Epub 2020 June 18
     View PubMed
131. Kunchok A, Flanagan EP, Snyder M, Saadeh R, Chen JJ, Weinshenker BG, McKeon A, Pittock SJ. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler. 2021 Apr; 27 (4):630-635 Epub 2020 July 07
     View PubMed
132. Singh TD, Hajeb M, Rabinstein AA, Kunchok AC, Pittock SJ, Krecke KN, Bartleson JD, Black DF. SMART syndrome: retrospective review of a rare delayed complication of radiation. Eur J Neurol. 2021 Apr; 28 (4):1316-1323 Epub 2020 Dec 03
     View PubMed
133. Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer M, Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021 Mar 1; 92 (8):897-907 Epub 2021 Mar 01
     View PubMed
134. Taraschenko O, Fox HS, Zekeridou A, Pittock SJ, Eldridge E, Farukhuddin F, Al-Saleem F, Devi Kattala C, Dessain SK, Casale G, Willcockson G, Dingledine R. Seizures and memory impairment induced by patient-derived anti-N-methyl-D-aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin-1 receptor antagonist. Epilepsia. 2021 Mar; 62 (3):671-682 Epub 2021 Feb 17
     View PubMed
135. Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021 Feb 9; 92 (6):645-54 Epub 2021 Feb 09
     View PubMed
136. Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, Weinshenker BG, Zalewski NL, Flanagan EP. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2021 Feb; 27 (2):303-308 Epub 2020 Feb 27
     View PubMed
137. McKeon A, Shelly S, Zivelonghi C, Basal E, Dubey D, Flanagan E, Madhavan AA, Mariotto S, Toledano M, Tracy JA, Zekeridou A, Pittock SJ. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers. Ann Clin Transl Neurol. 2021 Feb; 8 (2):425-439 Epub 2020 Dec 28
     View PubMed
138. Rozental AJ, McGrath S, Mooney AP, Hinson SR, McKeon A, Pittock SJ, Gross CC, Tyler KL. Evaluation of cell-based and tissue-based immunofluorescent assays for detection of glial fibrillary acidic protein autoantibodies in the cerebrospinal fluid of dogs with meningoencephalitis of unknown origin and other central nervous system disorders. Am J Vet Res. 2021 Feb; 82 (2):132-137
     View PubMed
139. Shah S, Vazquez Do Campo R, Kumar N, McKeon A, Flanagan EP, Klein C, Pittock SJ, Dubey D. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments. Neurology. 2021 Jan 26; 96 (4):e632-e639 Epub 2020 Nov 18
     View PubMed
140. Sechi E, Mariotto S, McKeon A, Krecke KN, Pittock SJ, Ferrari S, Monaco S, Flanagan EP, Zanzoni S, Rabinstein AA, Wingerchuk DM, Nasr DM, Zalewski NL. Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis. Stroke. 2021 Jan; 52 (2):645-654 Epub 2021 Jan 11
     View PubMed
141. Palace J, Wingerchuk DM, Fujihara K, Berthele A, Oreja-Guevara C, Kim HJ, Nakashima I, Levy M, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Yountz M, Miller L, Armstrong R, Pittock S, PREVENT Study Group. Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial. Mult Scler Relat Disord. 2021 Jan; 47:102641 Epub 2020 Nov 26
     View PubMed
142. Sechi E, Buciuc M, Flanagan EP, Pittock SJ, Banks SA, Lopez-Chiriboga AS, Bhatti MT, Chen JJ. Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder. Mult Scler Relat Disord 2021 Jan; 47:102638 Epub 2020 Nov 23
     View PubMed
143. Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021; 3 (2):fcaa233 Epub 2021 Jan 05
     View PubMed
144. Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020 Dec 28 [Epub ahead of print]
     View PubMed
145. Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, Jitprapaikulsan J, Hodge DO, Bhatti MT, Chen JJ. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Am J Ophthalmol. 2020 Dec; 220:110-114 Epub 2020 July 21
     View PubMed
146. Kunchok A, Chen JJ, Saadeh RS, Wingerchuk DM, Weinshenker BG, Flanagan EP, Pittock SJ. Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG-Associated Disorders. JAMA Neurol. 2020 Dec 1; 77 (12):1572-1575
     View PubMed
147. Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. JAMA Neurol. 2020 Dec 1; 77 (12):1575-1577
     View PubMed
148. Budhram A, Dubey D, Sechi E, Flanagan EP, Yang L, Bhayana V, McKeon A, Pittock SJ, Mills JR. Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis. Clin Chem. 2020 Dec 1; 66 (12):1496-1509
     View PubMed
149. Shelly S, Paul P, Bi H, Dubey D, Milone M, Sorenson EJ, Crum BA, Laughlin RS, Liewluck T, Mandrekar J, Pittock SJ, Zekeridou A, McKeon A, Harper MC, Mills JR, Klein CJ. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm. Neurology. 2020 Dec 1; 95 (22):e3002-e3011 Epub 2020 Sept 16
     View PubMed
150. Budhram A, Britton JW, Liebo GB, Dubey D, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Braksick SA, Zalewski NL. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis. J Neurol. 2020 Nov; 267 (11):3337-3342 Epub 2020 June 24
     View PubMed
151. Pittock SJ, Alfugham N, O'Connor K, Hinson S, Kunchok A, Lennon VA, Komorowski L, Probst C, McKeon A. GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy. Mov Disord Clin Pract. 2020 Nov; 7 (8):904-909 Epub 2020 Sept 14
     View PubMed
152. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
     View PubMed
153. Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13
     View PubMed
154. Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin B, Mathey G, Laplaud D, Thouvenot E, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett JL, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Jacob A. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Mult Scler Relat Disord. 2020 Sep; 44:102251 Epub 2020 June 02
     View PubMed
155. Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A. Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events. JAMA Neurol. 2020 Aug 1; 77 (8):937-946
     View PubMed
156. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
     View PubMed
157. Dubey D, Honorat JA, Shelly S, Klein CJ, Komorowski L, Mills JR, Brakopp S, Probst C, Lennon VA, Pittock SJ, McKeon A. Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates. Neurol Neuroimmunol Neuroinflamm. 2020 Jul; 7 (4) Epub 2020 May 27
     View PubMed
158. Paul P, McKeon A, Pittock SJ, Klein CJ, Shah S, Toledano M, Mills JR, Dubey D. GFAP IgG associated inflammatory polyneuropathy. J Neuroimmunol. 2020 Jun 15; 343:577233 Epub 2020 Apr 01
     View PubMed
159. Hoftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, Joldic D, Pittock SJ, Tillema JM, Gorman M, Lassmann H, Lucchinetti CF. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020 May; 139 (5):875-892 Epub 2020 Feb 11
     View PubMed
160. Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, Ritter N, Krummrei U, Stocker W, Eggert J, Flanagan EP, Ramberger M, Hegen H, Rostasy K, Berger T, Leite MI, Palace J, Irani SR, Dale RC, Probst C, Probst M, Brilot F, Pittock SJ, Waters P. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5; 7 (2) Epub 2020 Feb 05
     View PubMed
161. Shelly S, Mills JR, Martinez-Thompson JM, Rofforth MM, Pittock SJ, Mandrekar J, Triplett JD, Mauermann M, Dubey D, Klein CJ. IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS. J Neurol Neurosurg Psychiatry 2020 Mar; 91 (3):324-326 Epub 2019 Nov 22
     View PubMed
162. Jitprapaikulsan J, Klein CJ, Pittock SJ, Gadoth A, McKeon A, Mills JR, Dubey D. Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG. J Neurol Neurosurg Psychiatry 2020 Mar; 91 (3):328-330 Epub 2019 Dec 04
     View PubMed
163. Xu M, Bennett DLH, Querol LA, Wu LJ, Irani SR, Watson JC, Pittock SJ, Klein CJ. Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies. J Neurol Neurosurg Psychiatry. 2020 Feb; 91(2):177-188. Epub 2018 Sep 17.
     View PubMed
164. Kunchok A, Chen JJ, McKeon A, Mills JR, Flanagan EP, Pittock SJ. Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients. JAMA Neurol. 2020 Feb 1; 77 (2):257-259
     View PubMed
165. Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2020 Feb; 127 (2):221-229 Epub 2019 Sept 20
     View PubMed
166. Lopez-Chiriboga AS, Van Stavern G, Flanagan EP, Pittock SJ, Fryer J, Bhatti MT, Chen JJ. Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis. Neuroophthalmology. 2020 Feb; 44 (1):1-4 Epub 2019 May 28
     View PubMed
167. Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
     View PubMed
168. Kunchok A, Zekeridou A, Pittock S. CRMP5-IgG-Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy. JAMA Neurol. 2020 Feb 1; 77 (2):255-256
     View PubMed
169. Kunchok A, Krecke KN, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Chen JJ, Weinshenker BG, Pittock SJ. Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)? Neurology. 2020 Jan 14; 94 (2):85-88 Epub 2019 Dec 11
     View PubMed
170. Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT. Optic neuritis in the era of biomarkers. Surv Ophthalmol. 2020 Jan - Feb; 65 (1):12-17 Epub 2019 Aug 16
     View PubMed
171. Asnafi S, Morris PP, Sechi E, Pittock SJ, Weinshenker BG, Palace J, Messina S, Flanagan EP. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study. Mult Scler Relat Disord. 2020 Jan; 37:101487 Epub 2019 Oct 31
     View PubMed
172. Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, Jacob A, Marignier R, Weinshenker BG, Paul F, Pittock SJ, Palace J, Wingerchuk DM, Behne JM, Yeaman MR, Fujihara K. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 2020; 11:501 Epub 2020 June 26
     View PubMed
173. O'Donovan B, Mandel-Brehm C, Vazquez SE, Liu J, Parent AV, Anderson MS, Kassimatis T, Zekeridou A, Hauser SL, Pittock SJ, Chow E, Wilson MR, DeRisi JL. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display. Brain Commun. 2020; 2 (2):fcaa059 Epub 2020 Aug 03
     View PubMed
174. Cortez FJ, Gebhart D, Robinson PV, Seftel D, Pourmandi N, Owyoung J, Bertozzi CR, Wilson DM, Maahs DM, Buckingham BA, Mills JR, Roforth MM, Pittock SJ, McKeon A, Page K, Wolf WA, Sanda S, Speake C, Greenbaum CJ, Tsai CT. Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR. PLoS One. 2020; 15 (11):e0242049 Epub 2020 Nov 13
     View PubMed
175. Dubey D, Jitprapaikulsan J, Bi H, Do Campo RV, McKeon A, Pittock SJ, Engelstad JK, Mills JR, Klein CJ. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome. Neurology. 2019 Nov 12; 93 (20):e1873-e1880 Epub 2019 Oct 17
     View PubMed
176. Conway BL, Zeydan B, Uygunoglu U, Novotna M, Siva A, Pittock SJ, Atkinson EJ, Rodriguez M, Kantarci OH. Age is a critical determinant in recovery from multiple sclerosis relapses. Mult Scler. 2019 Nov; 25 (13):1754-1763 Epub 2018 Oct 10
     View PubMed
177. Turner LE, Pittock SJ, McEvoy MT, Flanagan EP. Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg. Neurol Neuroimmunol Neuroinflamm. 2019 Nov; 6 (6) Epub 2019 Sept 25
     View PubMed
178. Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A. Neurochondrin neurological autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2019 Nov; 6 (6) Epub 2019 Sept 11
     View PubMed
179. Burt RK, Balabanov R, Han X, Burns C, Gastala J, Jovanovic B, Helenowski I, Jitprapaikulsan J, Fryer JP, Pittock SJ. Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. Neurology. 2019 Oct 29; 93 (18):e1732-e1741 Epub 2019 Oct 02
     View PubMed
180. Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E, N-MOmentum study investigators. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet. 2019 Oct 12; 394 (10206):1352-1363 Epub 2019 Sept 05
     View PubMed
181. Lopez-Chiriboga S, Pittock SJ, Weinshenker BG, Chen JJ, Flanagan E. Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS. Mult Scler Relat Disord 2019 Oct; 35:34-35 Epub 2019 June 29
     View PubMed
182. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology. 2019 Sep 3; 93 (10):e954-e963 Epub 2019 Aug 01
     View PubMed
183. Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up. J Neurol Neurosurg Psychiatry. 2019 Sep; 90 (9):1021-1026 Epub 2019 May 22
     View PubMed
184. Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology. 2019 Aug 20; 93 (8):e815-e822 Epub 2019 July 17
     View PubMed
185. Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019 Aug 15; 381 (7):614-625 Epub 2019 May 03
     View PubMed
186. Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP. Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology. Neurology. 2019 Jul 23; 93 (4):e414-e420 Epub 2019 June 24
     View PubMed
187. Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ. Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. N Engl J Med. 2019 Jul 4; 381 (1):47-54
     View PubMed
188. Anis S, Regev K, Pittock SJ, Flanagan EP, Alcalay Y, Gadoth A. Isolated recurrent myelitis in a persistent MOG positive patient. Mult Scler Relat Disord. 2019 May; 30:163-164 Epub 2019 Feb 13
     View PubMed
189. Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders. Brain. 2019 May 1; 142 (5):1310-1323
     View PubMed
190. O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A. GABAA receptor autoimmunity: A multicenter experience. Neurol Neuroimmunol Neuroinflamm. 2019 May; 6 (3):e552 Epub 2019 Apr 04
     View PubMed
191. Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry 2019 Apr; 90 (4):488-490 Epub 2018 July 21
     View PubMed
192. Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019 Mar 12; 92(11):e1250-e1255. Epub 2019 Feb 06.
     View PubMed
193. Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis. Epilepsia. 2019 Mar; 60 (3):452-463 Epub 2019 Feb 11
     View PubMed
194. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1; 76 (3):301-309
     View PubMed
195. Lopez Chiriboga AS, Pittock S. Episodic ataxia in CASPR2 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2019 Mar; 6 (2):e536 Epub 2018 Dec 24
     View PubMed
196. Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ. Optical coherence tomography is highly sensitive in detecting prior optic neuritis. Neurology. 2019 Feb 5; 92 (6):e527-e535 Epub 2019 Jan 23
     View PubMed
197. Dubey D, Pittock SJ, McKeon A. Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability. Epilepsia 2019 Feb; 60 (2):367-369
     View PubMed
198. Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL. Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1. Ann Rheum Dis 2019 Jan; 78 (1):150-152 Epub 2018 Sept 05
     View PubMed
199. Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B, attendees of the International Neuroimmune Meeting. Author Correction: Neuroimmune disorders of the central nervous system in children in the molecular era. Nat Rev Neurol. 2018 Dec; 14 (12):749
     View PubMed
200. Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e497. Epub 2018 Aug 20.
     View PubMed
201. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 01; 75(11):1355-1363.
     View PubMed
202. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
     View PubMed
203. Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP. Population-based study of "no evident disease activity" in MS. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5 (6):e495 Epub 2018 Aug 16
     View PubMed
204. Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018 Oct 30; 91 (18):e1677-e1689 Epub 2018 Oct 03
     View PubMed
205. Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology. 2018 Oct 23; 91 (17):e1642-e1651 Epub 2018 Sept 26
     View PubMed
206. Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. 2018 Oct 15; 323:62-72 Epub 2018 July 25
     View PubMed
207. Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. 2018 Oct; 125 (10):1628-1637 Epub 2018 Apr 30
     View PubMed
208. Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies. Mayo Clin Proc. 2018 Sep; 93 (9):1299-1304 Epub 2018 Apr 11
     View PubMed
209. Feyissa AM, Lamb C, Pittock SJ, Gadoth A, McKeon A, Klein CJ, Britton JW. Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1. Epilepsia Open. 2018 Sep; 3 (3):348-356 Epub 2018 June 25
     View PubMed
210. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A. Autoimmune septin-5 cerebellar ataxia. Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5 (5):e474 Epub 2018 July 09
     View PubMed
211. Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480
     View PubMed
212. Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP. Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis. J Neuroophthalmol. 2018 Sep; 38 (3):276-281
     View PubMed
213. Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP. Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy. Neurology. 2018 Aug 28; 91 (9):414-417 Epub 2018 July 25
     View PubMed
214. Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A. Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year. J Neuroimmunol. 2018 Aug 15; 321:157-163 Epub 2018 Apr 27
     View PubMed
215. Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ. Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis. JAMA Neurol. 2018 Jul 1; 75 (7):892-895
     View PubMed
216. Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B, attendees of the International Neuroimmune Meeting. Neuroimmune disorders of the central nervous system in children in the molecular era. Nat Rev Neurol. 2018 Jul; 14 (7):433-445
     View PubMed
217. Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, Willrich MAV. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes. Clin Chem Lab Med. 2018 Jun 27; 56 (7):1071-1080
     View PubMed
218. Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ. Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM. Muscle Nerve. 2018 Jun; 57 (6):1000-1005 Epub 2018 Jan 26
     View PubMed
219. Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018 May; 89(5):526-534. Epub 2017 Oct 21.
     View PubMed
220. Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ. Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol. 2018 May; 5 (5):646-650 Epub 2018 Apr 02
     View PubMed
221. Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR, Hampe CS, T1D Exchange Biobank. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies. Orphanet J Rare Dis. 2018 Apr 10; 13 (1):55
     View PubMed
222. Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. JAMA Ophthalmol. 2018 Apr 1; 136 (4):419-422
     View PubMed
223. Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL. MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology. 2018 Mar; 60 (3):239-245 Epub 2018 Jan 20
     View PubMed
224. Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A. Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2018 Mar; 5 (2):e438 Epub 2018 Jan 23
     View PubMed
225. Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB. Breast cancer-related paraneoplastic neurologic disease. Breast Cancer Res Treat. 2018 Feb; 167 (3):771-778 Epub 2017 Nov 07
     View PubMed
226. Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology. 2018 Jan 9; 90 (2):e103-e110 Epub 2017 Dec 08
     View PubMed
227. Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ. ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association. Neurol Neuroimmunol Neuroinflamm. 2018 Jan; 5 (1):e418 Epub 2017 Dec 08
     View PubMed
228. Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan; 83 (1):166-177
     View PubMed
229. Zalewski N, Lennon VA, Pittock SJ, Mckeon A. Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting. Muscle Nerve. 2017 Dec 22 [Epub ahead of print]
     View PubMed
230. Martinez-Thompson JM, Pittock SJ, Milone M. PRES leading to the diagnosis of McArdle disease. J Clin Neurosci. 2017 Dec; 46:62-64 Epub 2017 Sept 05
     View PubMed
231. Shosha E, Pittock SJ, Flanagan E, Weinshenker BG. Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management. Mult Scler. 2017 Dec; 23 (14):1808-1817
     View PubMed
232. Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stuve O. B-cell-targeted therapies in relapsing forms of MS. Neurol Neuroimmunol Neuroinflamm. 2017 Nov; 4 (6):e405 Epub 2017 Oct 23
     View PubMed
233. Tobin WO, Pittock SJ. Erratum: Autoimmune neurology of the central nervous system CONTINUUM: Lifelong Learning in Neurology. 2017 Oct; 23 (5):1238
     
234. Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017 Sep; 4 (5):e385 Epub 2017 July 18
     View PubMed
235. Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017 Sep 1; 140 (9):2415-2425
     View PubMed
236. Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e343 Epub 2017 Apr 21
     View PubMed
237. Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017 Jul; 58 (7):1181-1189 Epub 2017 May 26
     View PubMed
238. Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017 Jul; 82 (1):79-92
     View PubMed
239. Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ. Dacrystic seizures-a cry for help. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e372 Epub 2017 June 16
     View PubMed
240. Tobin WO, Pittock SJ. Autoimmune neurology of the central nervous system CONTINUUM: Lifelong Learning in Neurology. 2017 Jun; 23: (3)627-53.
     
241. Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ. Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy. Muscle Nerve. 2017 Apr; 55 (4):520-525 Epub 2017 Feb 13
     View PubMed
242. Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica. Acta Neuropathol. 2017 Apr; 133 (4):597-612 Epub 2017 Feb 09
     View PubMed
243. Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2017 Mar; 88 (3):218-225 Epub 2016 Dec 02
     View PubMed
244. Dubey D, Pittock SJ, Krecke KN, Flanagan EP. Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2017 Mar 1; 74 (3):359-361
     View PubMed
245. Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker. Ann Neurol. 2017 Feb; 81: (2)266-277.
     View PubMed
246. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol. 2017 Feb; 81 (2):298-309
     View PubMed
247. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients Annals of Neurology. 2017; 81: (2)298-309.
     
248. Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker Annals of Neurology. 2017; 81: (2)266-77.
     
249. Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ. Clinical/scientific notes: Dacrystic seizures: A cry for help Neurology: Neuroimmunology and NeuroInflammation. 2017; 4: (4)e372.
     
250. Flanagan EP, Pittock SJ. Diagnosis and management of spinal cord emergencies. Handb Clin Neurol. 2017; 140:319-335
     View PubMed
251. Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A. IgLON5 antibody Neurology: Neuroimmunology and NeuroInflammation. 2017; 4 (5):385
     
252. Alfugham N, Roforth M, Komorowski L, Ott A, Meyer W, Probst C, Lennon VA, Pittock SJ, McKeon A. A comparison of tissue-based and recombinant protein-based assays for detecting PCA-Tr/DNER-IgG. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3 (6):e294 Epub 2016 Oct 28
     View PubMed
253. Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurol. 2016 Nov 1; 73 (11):1297-1307
     View PubMed
254. Linnoila J, Pittock SJ. Autoantibody-Associated Central Nervous System Neurologic Disorders. Semin Neurol. 2016 Aug; 36 (4):382-96 Epub 2016 Sept 19
     View PubMed
255. Zalewski NL, Lennon VA, Lachance DH, Klein CJ, Pittock SJ, Mckeon A. P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments. Muscle Nerve. 2016 Aug; 54 (2):220-7 Epub 2016 Feb 08
     View PubMed
256. Cree BA, Bennett JL, Sheehan M, Cohen J, Hartung HP, Aktas O, Kim HJ, Paul F, Pittock S, Weinshenker B, Wingerchuk D, Fujihara K, Cutter G, Patra K, Flor A, Barron G, Madani S, Ratchford JN, Katz E. Placebo-controlled study in neuromyelitis optica-Ethical and design considerations. Mult Scler. 2016 Jun; 22 (7):862-72 Epub 2015 Dec 14
     View PubMed
257. Apiwattanakul M, Milone M, Pittock SJ, Kryzer TJ, Fryer JP, O'toole O, Mckeon A, Lennon VA. Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy. Muscle Nerve. 2016 Jun; 53 (6):925-32 Epub 2016 Feb 05
     View PubMed
258. Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians. Neurol Neuroimmunol Neuroinflamm. 2016 Jun; 3 (3):e231 Epub 2016 Apr 20
     View PubMed
259. Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016 May; 79 (5):775-783 Epub 2016 Apr 04
     View PubMed
260. Mittal MK, Rabinstein AA, Hocker SE, Pittock SJ, Wijdicks EF, McKeon A. Autoimmune Encephalitis in the ICU: Analysis of Phenotypes, Serologic Findings, and Outcomes. Neurocrit Care. 2016 Apr; 24 (2):240-50
     View PubMed
261. Lopez-Chiriboga AS, Komorowski L, Kumpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A. Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes. Neurology. 2016 Mar 15; 86 (11):1009-13 Epub 2016 Feb 17
     View PubMed
262. Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016 Mar; 79 (3):437-47 Epub 2016 Feb 12
     View PubMed
263. Pittock SJ. Demyelinating disease: NMO spectrum disorders: clinical or molecular classification? Nat Rev Neurol. 2016 Mar; 12 (3):129-30 Epub 2016 Feb 05
     View PubMed
264. Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2016 Feb; 1366 (1):20-39 Epub 2015 June 10
     View PubMed
265. Jurynczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Seze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. J Neurol. 2016 Jan; 263 (1):140-9 Epub 2015 Nov 03
     View PubMed
266. Pittock SJ, Vincent A. Introduction to autoimmune neurology. Handb Clin Neurol. 2016; 133:3-14.
     View PubMed
267. Pittock SJ, Palace J. Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment. Handb Clin Neurol. 2016; 133:165-83.
     View PubMed
268. Hinson SR, Lennon VA, Pittock SJ. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. Handb Clin Neurol. 2016; 133:377-403.
     View PubMed
269. Hu MY, Stathopoulos P, O'connor KC, Pittock SJ, Nowak RJ. Current and future immunotherapy targets in autoimmune neurology. Handb Clin Neurol. 2016; 133:511-36.
     View PubMed
270. Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2 (6):e161 Epub 2015 Oct 01
     View PubMed
271. Barnidge DR, Kohlhagen MC, Zheng S, Willrich MA, Katzmann JA, Pittock SJ, Murray DL. Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry. J Neuroimmunol. 2015 Nov 15; 288:123-6.
     View PubMed
272. Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults. JAMA Neurol. 2015 Nov; 72 (11):1304-12
     View PubMed
273. Novotna M, Paz Soldan MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 2015 Aug 25; 85 (8):722-9 Epub 2015 July 24
     View PubMed
274. Tobin WO, Pittock SJ, Weinshenker BG, Yan Z. Teaching NeuroImages: Primary Sjogren syndrome presenting as isolated lesion of medulla oblongata. Neurology. 2015 Jul 14; 85(2):204-5.
     View PubMed
275. Toledano M, Pittock SJ. Autoimmune Epilepsy. Semin Neurol. 2015 Jun; 35: (3)245-58.
     View PubMed
276. Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. Psychosomatics. 2015 May-Jun; 56 (3):227-41 Epub 2015 Feb 04
     View PubMed
277. Flanagan EP, Weinshenker BG, Krecke KN, Pittock SJ. Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy. Neurol Clin Pract. 2015 Apr; 5 (2):175-177
     View PubMed
278. Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Bruck W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology. 2015 Jan 13; 84 (2):148-58 Epub 2014 Dec 10
     View PubMed
279. Paz Soldan MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH. Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 2015 Jan 6; 84 (1):81-8 Epub 2014 Nov 14
     View PubMed
280. Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015 Jan; 72 (1):81-7
     View PubMed
281. Tobin WO, Strand EA, Clark HM, Lowe VJ, Robertson CE, Pittock SJ. NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging. Neurol Clin Pract. 2014 Dec; 4 (6):470-473
     View PubMed
282. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Nov 11; 83 (20):1797-803 Epub 2014 Oct 15
     View PubMed
283. McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers. Neurology. 2014 Nov 11; 83 (20):1789-96 Epub 2014 Sept 26
     View PubMed
284. Pittock SJ, Lennon VA, Bakshi N, Shen L, McKeon A, Quach H, Briggs FB, Bernstein AL, Schaefer CA, Barcellos LF. Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis. JAMA Neurol. 2014 Nov; 71(11):1433-6.
     View PubMed
285. Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM. Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimmunol. 2014 Oct; 5 (3):290-303 Epub 2014 Apr 22
     View PubMed
286. Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, Szarka LA, Murray JA, Foxx-Orenstein AE, Fox JC, Pittock SJ. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014 Sep; 26 (9):1285-97 Epub 2014 July 20
     View PubMed
287. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 2014 Aug; 13 (8):795-806 Epub 2014 July 06
     View PubMed
288. Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol. 2014 Aug; 71(8):1025-9.
     View PubMed
289. Horta ES, Lennon VA, Lachance DH, Jenkins SM, Smith CY, McKeon A, Klein C, Pittock SJ. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014 Jul 15; 20(14):3862-9. Epub 2014 May 15.
     View PubMed
290. Flanagan EP, Leep Hunderfund AN, Kumar N, Murray JA, Krecke KN, Katz BS, Pittock SJ. Clinical reasoning: a 55-year-old man with weight loss, ataxia, and foot drop. Neurology. 2014 Jun 17; 82 (24):e214-9
     View PubMed
291. Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, Weinshenker BG, Wingerchuk DM, McKeon A. AQP4 autoantibody assay performance in clinical laboratory service. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1 (1):e11 Epub 2014 May 22
     View PubMed
292. Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology. 2014 May 20; 82 (20):1841-3 Epub 2014 Apr 23
     View PubMed
293. Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AM, So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell EC, Nickels KC, Pittock SJ. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014 May 6; 82 (18):1578-86 Epub 2014 Apr 04
     View PubMed
294. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol. 2014 Apr; 71 (4):495-8
     View PubMed
295. Braksick SA, Cutsforth-Gregory JK, Black DF, Weinshenker BG, Pittock SJ, Kantarci OH. Teaching neuroimages: MRI in advanced neuromyelitis optica. Neurology. 2014 Mar 25; 82: (12)e101-2.
     View PubMed
296. Sandy S, Pittock SJ, Seemungal TAR, Ali A. Aquaporin-4 immuneglobulin G testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease. Neurology International. 2014; 6(3):40-2.
     
297. Iorio R, Pittock SJ. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies. Clinical and Experimental Neuroimmunology. 2014; 5(2):175-87.
     
298. Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014 Jan; 71 (1):48-54
     View PubMed
299. Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AM, Shin C, Klein CJ. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol. 2014 Jan; 35(1):84-9. Epub 2013 Jul 18
     View PubMed
300. Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, Harper CM Jr, Matsumoto JY, McKeon A. Childhood onset of stiff-man syndrome. JAMA Neurol. 2013 Dec; 70 (12):1531-6
     View PubMed
301. Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013 Nov; 88 (11):1204-12
     View PubMed
302. Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 Oct 1; 81 (14):1197-204 Epub 2013 Aug 30
     View PubMed
303. Jeffery OJ, Lennon VA, Pittock SJ, Gregory JK, Britton JW, McKeon A. GABAB receptor autoantibody frequency in service serologic evaluation. Neurology. 2013 Sep 3; 81 (10):882-7 Epub 2013 Aug 07
     View PubMed
304. Toledano M, Siddiqui MA, Thompson CA, Garza I, Pittock SJ. Teaching NeuroImages: diagnostic utility of FDG-PET in neurolymphomatosis. Neurology. 2013 Jul 2; 81 (1):e3
     View PubMed
305. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun; 12(6):554-62. Epub 2013 Apr 26.
     View PubMed
306. McKeon A, Lennon VA, LaChance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve. 2013 Apr; 47(4):585-7. Epub 2013 Mar 05.
     View PubMed
307. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80 (12):1133-44 Epub 2013 Feb 20
     View PubMed
308. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):240-5. Epub 2012 Dec 01.
     View PubMed
309. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013 Feb; 70 (2):229-34
     View PubMed
310. Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun. 2013 Feb; 40:21-7 Epub 2012 Aug 18
     View PubMed
311. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013 Feb; 19 (2):188-98 Epub 2012 June 26
     View PubMed
312. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70 (1):44-50
     View PubMed
313. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607.
     View PubMed
314. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012 Nov; 46(5):823-7.
     View PubMed
315. Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS. A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. Retina. 2012 Oct; 32(9):1959-66.
     View PubMed
316. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients. J Neurol Sci. 2012 Sep 15; 320(1-2):118-20. Epub 2012 Jul 24.
     View PubMed
317. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012 Sep 11; 79 (11):1136-44 Epub 2012 Aug 15
     View PubMed
318. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 Aug; 69 (8):1039-43
     View PubMed
319. Tarula E, Ramkissoon S, Pittock S, Sheen VL. Progressive mental status changes and seizures with fluid attenuated inversion recovery (FLAIR) hyperintensity on brain MRI. J Clin Neurosci. 2012 Jun; 19(6):873, 924.
     View PubMed
320. Eggers SD, Pittock SJ, Shepard NT, Habermann TM, Neff BA, Klebig RR. Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma. Neurology. 2012 May 29; 78 (22):1800-2 Epub 2012 May 16
     View PubMed
321. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012 May; 69 (5):582-93
     View PubMed
322. Bunyan RF, Pittock SJ. Do not treat from CIS onset: evaluate disease course and prognosis first--yes. Mult Scler. 2012 Apr; 18(4):391-3.
     View PubMed
323. Paz Soldan MM, Pittock SJ, Weigand SD, Yawn BP, Rodriguez M. Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler. 2012 Mar; 18 (3):358-63 Epub 2011 Sept 09
     View PubMed
324. Meeusen JW, Klein CJ, Pirko I, Haselkorn KE, Kryzer TJ, Pittock SJ, Lachance DH, Dyck PJ, Lennon VA. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012 Mar; 71 (3):417-26
     View PubMed
325. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 Feb 28; 78(9):665-71; discussion 669. Epub 2012 Feb 01.
     View PubMed
326. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69 (2):230-8
     View PubMed
327. Storoni M, Pittock SJ, Weinshenker BG, Plant GT. Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage. J Neurol Sci. 2012 Jan 15; 312(1-2):21-5. Epub 2011 Sep 14.
     View PubMed
328. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Erratum: Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients (Journal of the Neurological Sciences (2012) 320 (118-120)). J Neurol Sci. 2012; 323(1-2):273.
     
329. Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher. 2011 Dec; 26 (6):356-61 Epub 2011 Sept 05
     View PubMed
330. Caplan JP, Binius T, Lennon VA, Pittock SJ, Rao MS. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics. 2011 Nov-Dec; 52(6):501-6. Epub 2011 Sep 22.
     View PubMed
331. Iorio R, Lucchinetti CF, Lennon VA, Costanzi C, Hinson S, Weinshenker BG, Pittock SJ. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology. 2011 Oct 25; 77 (17):1644-6 Epub 2011 Oct 12
     View PubMed
332. McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011 Oct; 68(10):1282-9. Epub 2011 Jun 13.
     View PubMed
333. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011 Oct; 122(4):381-400. Epub 2011 Sep 22.
     View PubMed
334. Klein CJ, Kimmel GW, Pittock SJ, Engelstad JE, Cunningham JM, Wu Y, Dyck PJ. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol. 2011 Oct; 68 (10):1295-302
     View PubMed
335. Somers KJ, Lennon VA, Rundell JR, Pittock SJ, Drubach DA, Trenerry MR, Lachance DH, Klein CJ, Aston PA, McKeon A. Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci. 2011 Fall; 23: (4)425-33.
     View PubMed
336. Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, Thapa P, McKeon A. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology. 2011 Aug 16; 77 (7):659-66 Epub 2011 Aug 03
     View PubMed
337. Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Continuum.2011 Aug;17:(4):776-99.
     
338. Rudzinski LA, Pittock SJ, McKeon A, Lennon VA, Britton JW. Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res. 2011 Aug; 95(3):255-62. Epub 2011 May 12.
     View PubMed
339. Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul; 68 (7):870-8 Epub 2011 Mar 14
     View PubMed
340. Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011 Jun 14; 76(24):2089-95.
     View PubMed
341. Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011 Jun; 68 (6):733-8
     View PubMed
342. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56 (5):1452-9 Epub 2010 Dec 23
     View PubMed
343. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011 Apr 5; 76 (14):1229-37 Epub 2011 Mar 02
     View PubMed
344. Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol. 2011 Apr; 44 (4):275-81
     View PubMed
345. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology. 2011 Mar 22; 76 (12):1108-10
     View PubMed
346. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. "Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images": Correction. Arch Neurol. 2011 Mar; 68(3):371.
     
347. McKeon A, Lindell EP, Atkinson JL, Weinshenker BG, Piepgras DG, Pittock SJ. Pearls & oy-sters: clues for spinal dural arteriovenous fistulae. Neurology. 2011 Jan 18; 76(3):e10-2.
     View PubMed
348. Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol. 2011 Jan; 230 (1-2):130-4 Epub 2010 Nov 06
     View PubMed
349. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 Dec 7; 75 (23):2103-9
     View PubMed
350. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov; 68 (5):757-61
     View PubMed
351. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85 (10):881-97
     View PubMed
352. Fischer PR, Sandroni P, Pittock SJ, Porter CB, Lehwald LM, Raj SR. Isolated sympathetic failure with autoimmune autonomic ganglionopathy. Pediatr Neurol. 2010 Oct; 43(4):287-90.
     View PubMed
353. Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V, McKeon A, Fealey RD, Weinshenker BG, Aksamit AJ, Krueger BR, Shuster EA, Keegan BM. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010 Sep; 133(9):2626-34. Epub 2010 Jul 17.
     View PubMed
354. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15.
     View PubMed
355. Chamberlain JL, Pittock SJ, Oprescu AM, Dege C, Apiwattanakul M, Kryzer TJ, Lennon VA. Peripherin-IgG association with neurologic and endocrine autoimmunity. J Autoimmun. 2010 Jun; 34 (4):469-77 Epub 2010 Jan 12
     View PubMed
356. Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry. 2010 Jun; 81 (6):619-22 Epub 2010 Feb 22
     View PubMed
357. Apiwattanakul M, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010 May; 41(5):702-4.
     View PubMed
358. McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, Mullan B, Mokri B, Britton JW, Drubach DA, Pittock SJ. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010 Mar; 67 (3):322-9 Epub 2010 Jan 11
     View PubMed
359. Kraichely RE, Farrugia G, Pittock SJ, Castell DO, Lennon VA. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2010 Feb; 55 (2):307-11 Epub 2009 June 05
     View PubMed
360. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9 (1):55-66 Epub 2009 Nov 27
     View PubMed
361. Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):109-11.
     View PubMed
362. Lim SY, Mason WP, Young NP, Chen R, Bower JH, McKeon A, Pittock SJ, Lang AE. Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies. Arch Neurol. 2009 Oct; 66(10):1285-7.
     View PubMed
363. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009 Sep; 66(9):1164-7.
     View PubMed
364. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009 Sep; 66 (9):1134-8
     View PubMed
365. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009 Sep; 66 (9):1128-33
     View PubMed
366. Magana SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009 Aug; 66 (8):964-6
     View PubMed
367. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009 Jun; 66 (6):735-41
     View PubMed
368. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 Feb 24; 72(8):712-7.
     View PubMed
369. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol. 2009 Feb; 66(2):268-71.
     View PubMed
370. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009 Jan; 39(1):87-90.
     View PubMed
371. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 Oct 27; 205 (11):2473-81 Epub 2008 Oct 06
     View PubMed
372. Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 2008 Oct; 65 (10):1341-6
     View PubMed
373. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008 Sep; 6 (9):988-92 Epub 2008 July 02
     View PubMed
374. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8; 71 (2):93-100 Epub 2008 May 28
     View PubMed
375. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 Jul; 131 (Pt 7):1759-75 Epub 2008 June 05
     View PubMed
376. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 Jun 3; 70(23):2197-200. Epub 2008 Apr 23.
     View PubMed
377. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008 May 13; 70 (20):1883-90
     View PubMed
378. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008 May; 65 (5):629-32
     View PubMed
379. Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol. 2008 Apr; 63 (4):531-4
     View PubMed
380. Pittock SJ. Neuromyelitis optica: a new perspective. Semin Neurol. 2008 Feb; 28: (1)95-104.
     View PubMed
381. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 Jan 29; 70(5):344-52. Epub 2007 Dec 19
     View PubMed
382. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 Jan; 65 (1):78-83
     View PubMed
383. Pittock SJ, Rodriguez M. Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. Curr Top Microbiol Immunol. 2008; 318:1-17
     View PubMed
384. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11; 69 (24):2221-31 Epub 2007 Oct 10
     View PubMed
385. McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE. Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol. 2007 Sep; 64 (9):1318-22
     View PubMed
386. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep; 6 (9):805-15
     View PubMed
387. McKeon A, Ozelius LJ, Hardiman O, Greenway MJ, Pittock SJ. Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred. Mov Disord. 2007 Jul 15; 22(9):1325-7.
     View PubMed
388. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol. 2007 Jul; 187(1-2):126-38. Epub 2007 May 21.
     View PubMed
389. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 May; 130 (Pt 5):1194-205 Epub 2007 Feb 04
     View PubMed
390. Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist. 2007 Mar; 13(2):45-56.
     View PubMed
391. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 Feb 20; 68 (8):603-5
     View PubMed
392. Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler. 2007 Jan; 13: (1)7-16.
     View PubMed
393. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol. 2006 Oct; 63(10):1398-400.
     View PubMed
394. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006 Sep; 81 (9):1207-14
     View PubMed
395. Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol. 2006 Aug; 19 (4):362-8
     View PubMed
396. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul; 63 (7):964-8
     View PubMed
397. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23; 66 (10):1485-9
     View PubMed
398. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar; 63 (3):390-6
     View PubMed
399. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 Mar; 59 (3):566-9
     View PubMed
400. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63 (2):197-202
     View PubMed
401. Lin F, Murphy R, White B, Kelly J, Feighery C, Doyle R, Pittock S, Moroney J, Smith O, Livingstone W, Keenan C, Jackson J. Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation. Lupus. 2006; 15(2):87-93.
     View PubMed
402. Weinshenker B, Wingerchuk D, Pittock S, Lucchinetti C, Lennon V. A Secondary Progressive Clinical Course is Uncommon in Neuromyelitis Optica. Neurology. 2006.
     
403. Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006; 22 (4):197-206
     View PubMed
404. Pittock SJ, Rodriguez M. Disability in multiple sclerosis. Is MS a more benign condition than previously supposed? Cuadernos de Esclerosis Multiple. 2006.
     
405. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry. 2005 Dec; 76 (12):1693-7
     View PubMed
406. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 Aug 15; 202 (4):473-7 Epub 2005 Aug 08
     View PubMed
407. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005 Jul; 58(1):96-107.
     View PubMed
408. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17; 364 (9451):2106-12
     View PubMed
409. Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004 Dec; 19 (12):1482-5
     View PubMed
410. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004 Nov; 56 (5):715-9
     View PubMed
411. Pittock SJ, Weinshenker BG, Wijdicks EF. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004 Sep; 75 (9):1331-3
     View PubMed
412. Meldrum D, Pittock SJ, Hardiman O, Ni Dhuill C, O'Regan M. Recovery of the upper limb post ischaemic stroke and the predictive value of the Orpington Prognostic Score. Clin Rehabil. 2004 Sep; 18(6):694-702.
     View PubMed
413. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol. 2004 Aug; 56 (2):303-6
     View PubMed
414. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004 Jun; 19(6):695-9.
     View PubMed
415. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004 May; 61(5):679-86.
     View PubMed
416. Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, De Andrade M, McMurray CT, Rodriguez M, Rodriguez M, Weinshenker BG. Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology. 2004 Mar 9; 62 (5):811-4
     View PubMed
417. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M, Rodriguez M. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology. 2004 Feb 24; 62 (4):601-6
     View PubMed
418. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Weinshenker BG, Rodriguez M, Rodriguez M. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology. 2004 Jan 13; 62 (1):51-9
     View PubMed
419. Balding J, Livingstone WJ, Pittock SJ, et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. IJMS. 2004; 173(4):200-3.
     
420. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology. 2003 Nov 25; 61 (10):1373-7
     View PubMed
421. Rabinstein AA, Pittock SJ, Miller GM, Schindler JJ, Wijdicks EF. Pseudosubarachnoid haemorrhage in subdural haematoma. J Neurol Neurosurg Psychiatry. 2003 Aug; 74 (8):1131-2
     View PubMed
422. Pittock SJ, Meldrum D, Ni Dhuill C, Hardiman O, Moroney JT. The Orpington Prognostic Scale within the first 48 hours of admission as a predictor of outcome in ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jul-Aug; 12(4):175-81.
     View PubMed
423. Pittock SJ, Meldrum D, Hardiman O, Deane C, Dunne P, Hussey A, Gorman M, Moroney JT. Patient and hospital delays in acute ischaemic stroke in a Dublin teaching hospital. Ir Med J. 2003 Jun; 96(6):167-8 170-1.
     View PubMed
424. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol 2003 May; 53(5):580-7.
     View PubMed
425. Pittock SJ, Rabinstein AA, Edwards BS, Wijdicks EFM. OKT3 neurotoxicity presenting as akinetic mutism. Transplantation. 2003 Apr 15; 75(7):1058-60.
     View PubMed
426. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003; 15(4):289-300.
     View PubMed
427. Pittock SJ, Meldrum D, Hardiman O, Thornton J, Brennan P, Moroney JT. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jan; 12(1):1-7.
     View PubMed
428. Pittock SJ, Meldrum D, Hardiman O. The "spray can" sign: validation of a clinical observation in chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2002 Oct; 59(10):1637-40.
     View PubMed
429. Pittock SJ. Unilateral osteoarthritis--"the working hand". N Engl J Med. 2002 Mar 7; 346(10):e3.
     View PubMed
430. Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin Proc. 2002 Mar; 77 (3):291-4
     View PubMed
431. Pittock SJ, Rodriguez M, Rodriguez M, Wijdicks EF. Rapid weaning from mechanical ventilator in acute cervical cord multiple sclerosis lesion after steroids. Anesth Analg. 2001 Dec; 93 (6):1550-1, table of contents
     View PubMed
432. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001 Nov; 8(6):559-65.
     View PubMed
433. Henderson RD, Pittock SJ, Piepgras DG, Wijdicks EF. Acute spontaneous spinal epidural hematoma. Arch Neurol. 2001 Jul; 58 (7):1145-6
     View PubMed
434. Pittock SJ, Hardiman O, Goode B, Moroney JT. Evaluation of stroke management in an Irish university teaching hospital: the Royal College of Physicians stroke audit package. Ir J Med Sci. 2001 Jul-Sep; 170(3):163-8.
     View PubMed
435. Pittock SJ, Moroney JT, Alexander M, Brennan P, Moorhouse D. Traumatic bilateral carotid dissection with concomitant cerebral infarction. J Emerg Med. 2001 Jan; 20(1):33-8.
     View PubMed
436. Pittock SJ, Joyce C, O’Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology. 2000 Oct 10; 55(7):991-5.
     View PubMed
437. Ni Dhuill CM, Fox GB, Pittock SJ, O’Connell AW, Murphy KJ, Regan CM. Polysialylated neural cell adhesion molecule expression in the dentate gyrus of the human hippocampal formation from infancy to old age. J Neurosci Res. 1999 Jan 1; 55(1):99-106.
     View PubMed